Literature DB >> 21574898

Complete reversal of nephrotic syndrome secondary to amyloidosis with use of infliximab in a patient with inflammatory bowel disease and ankylosing spondylitis.

Mehmet Fatih Akdoğan1, Murat Gücün, Nazım Denizli, Murat Güney, Ibrahim Akdag, Tevhide Bilgen Ozcan, Murat Duranay.   

Abstract

A 30-year-old woman was diagnosed with ulcerative colitis in January 2006. One year later, she presented because of severe back pain and was diagnosed with ankylosing spondylitis (AS). In February 2008, the patient, while still under standard treatment for ulcerative colitis and AS, was admitted because of massive proteinuria and related symptoms. Nephrotic syndrome was observed and renal biopsy revealed amyloid deposits. After treatment with infliximab, nephrotic syndrome disappeared. We aim to present a case of secondary amyloidosis complicating ulcerative colitis and associated spondyloarthropathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21574898     DOI: 10.3109/0886022X.2011.577543

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  3 in total

Review 1.  Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pediatr Nephrol       Date:  2015-05-05       Impact factor: 3.714

2.  A case report on nephrotic syndrome associated with ankylosing spondylitis effectively treated with infliximab.

Authors:  Xin Feng; Yao Li; Wei Gao
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 3.  Gastrointestinal Amyloidosis: Review of the Literature.

Authors:  Kyle Rowe; Jon Pankow; Fredy Nehme; William Salyers
Journal:  Cureus       Date:  2017-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.